ArticleJournal of managed care & specialty pharmacy2017

Application of the FDA Biosimilar Extrapolation Framework to Make Off-Label Determinations.

Edward Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.